Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Yu EJ, Bell DW. The endometrial cancer A230V-ALK5 (TGFBR1) mutant attenuates TGF-beta signaling and exhibits reduced in vitro sensitivity to ALK5 inhibitors. PLoS One 2024;19:e0312806.
PMID: 39576826


Privacy Policy